首页> 外文期刊>Current sports medicine reports. >Implantable cardioverter defibrillators in athletes: rationale for use and issues surrounding return to play.
【24h】

Implantable cardioverter defibrillators in athletes: rationale for use and issues surrounding return to play.

机译:运动员体内植入的心脏复律除颤器:使用原理和围绕重返比赛的问题。

获取原文
获取原文并翻译 | 示例
       

摘要

Although the 36~th Bethesda Guidelines for sports participation recommend that athletes with implanted cardioverter-defibrillators (ICDs) be disqualified from participating in sports (1), surveys of implanting physicians and sports medicine specialists indicate that the majority of athletes with ICDs are participating in some form of sports activity (2,3).ICDs are implanted to treat episodes of sudden cardiac arrest (SCA) caused by ventricular fibrillation (VF) in high-risk individuals. Such individuals are identified either by having experienced a prior VF episode from which they were resuscitated (secondary prevention patient) or by having an underlying high-risk cardiac condition known to pre-dispose to VF (primary prevention patient). The epidemiology of SCA differs significantly in the athletic population compared with the general population, but the indications for ICD implant are the same in all patient groups (4).
机译:尽管第36届《贝塞斯达运动参与指南》建议取消具有植入式心脏除颤器(ICD)的运动员参加运动的资格(1),但对植入医生和运动医学专家的调查表明,大多数具有ICD的运动员都参加了运动某种形式的体育活动(2,3).ICD被植入以治疗高危个体因室颤(VF)引起的心脏骤停(SCA)发作。可以通过经历过先前的VF发作(二级预防患者)或已知具有潜在易患VF的潜在高危心脏病(一级预防患者)来识别此类个体。与普通人群相比,SCA的流行病学差异显着,但在所有患者组中,ICD植入的适应症均相同(4)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号